Evidence map›Paper›PMID 34377154›Full record

ArticleTherapeutic advances in urology

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center.

Pasquale Annese, Nicola d'Altilia, Vito Mancini, Ugo G Falagario, Francesco Del Giudice, Matteo Ferro, Ottavio de Cobelli, Angelo Porreca, Gian Maria Busetto, Giuseppe Carrieri

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Pasquale AnneseDepartment of Urology and Organ Transplantation, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Nicola d'AltiliaDepartment of Urology and Organ Transplantation, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Vito ManciniDepartment of Urology and Organ Transplantation, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Ugo G FalagarioDepartment of Urology and Organ Transplantation, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Francesco Del GiudiceDepartment Maternal-Child and Urological Sciences, Sapienza Rome University, Policlinico Umberto I, Rome, Italy.
Matteo FerroDepartment of Urology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0003-4687-7353
Ottavio de CobelliDepartment of Urology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
Angelo PorrecaVeneto Institute of Oncology (IOV), IRCCS, Padua, Italy.
Gian Maria BusettoDepartment of Urology and Renal Transplantation, University of Foggia, Policlinico Riuniti, Viale Luigi Pinto, 1, Foggia, 71122, Italy.ORCID https://orcid.org/0000-0002-7291-0316
Giuseppe CarrieriDepartment of Urology and Organ Transplantation, University of Foggia, Policlinico Riuniti, Foggia, Italy.
University of Foggia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Oncologico Veneto · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsProstatic urethral lift (Urolift™) is a minimally invasive technique to treat male lower urinary tract symptoms (LUTSs) due to benign prostatic hyperplasia (BPH). The aim of the present study was to assess safety and medium- to long-term outcomes in the relief of urinary symptoms.

methodsWe included 35 men, affected by severe symptomatic BPH evaluated by International Prostate Symptom Score (IPSS), with normal erectile function (EF) and ejaculatory function (EjF) evaluated by the International Index of Erectile Dysfunction (IIEF-5) and Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD-SF). Exclusion criteria were prostate larger than 70 cm

resultsAll procedures were performed by a single senior surgeon and follow-up was 33.8 ± 12 months. Preoperative PSA was 0.82 ± 0.4 ng/ml and mean operative time was 19.6 ± 10 min and 3 (2-4) implants per patient were used. Parameters reported at last follow-up schedule were: Q-max increase of 68% (

conclusionUrolift can improve urinary disorders secondary to BPH, preserving EjF and EF. It is a safe and easy method, reproducible, and with low incidence of complications. Careful selection of patients is mandatory. The main reason for dissatisfaction is the higher expectation of better BPH symptoms relief although patients with high bladder neck and/or prostate volume >45 cm

Indexed as

BPHejaculationLUTSprostatic urethral lift

Identifiers

PMID34377154
PMCPMC8326815
OpenAlexW3191231213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.